Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey M Fernandes

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Advanced Biosystems|April 23, 2019
Enhanced activation and expansion of T cells using mechanically soft elastomer fibersAlex Dang, Sarah De Leo, Danielle R Bogdanowicz, et al.
Leukemia|May 14, 2022
Idelalisib activates AKT via increased recruitment of PI3Kδ/PI3Kβ to BCR signalosome while reducing PDK1 in post-therapy CLL cellsMurali K Mamidi, Hasan Mahmud, Guru P Maiti, et al.
Blood|October 21, 2017
Analysis of <i>ITGB2</i> rare germ line variants in chronic lymphocytic leukemiaGrace Tiao, M Reina Improgo, Eugen Tausch, et al.
Genome Biology|June 3, 2026
Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Blood|March 8, 2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemiaIshwarya Murali, Siddha Kasar, Aishath Naeem, et al.
Genome Biology|April 16, 2026
Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Blood|July 1, 2020
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLLMarco V Haselager, Karoline Kielbassa, Johanna Ter Burg, et al.
British Journal of Haematology|December 12, 2018
MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLLMa Reina Improgo, Bethany Tesar, Josephine L Klitgaard, et al.
Leukemia|July 28, 2025
Rare germline variant in NFATC4 associated with familial CLLGilad Itchaki, Harrison Bai, Grace Tiao, et al.
Haematologica|July 1, 2021
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisibVeronika Sandova, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Advanced Biosystems|April 23, 2019
Enhanced activation and expansion of T cells using mechanically soft elastomer fibersAlex Dang, Sarah De Leo, Danielle R Bogdanowicz, et al.
Leukemia|May 14, 2022
Idelalisib activates AKT via increased recruitment of PI3Kδ/PI3Kβ to BCR signalosome while reducing PDK1 in post-therapy CLL cellsMurali K Mamidi, Hasan Mahmud, Guru P Maiti, et al.
Blood|October 21, 2017
Analysis of <i>ITGB2</i> rare germ line variants in chronic lymphocytic leukemiaGrace Tiao, M Reina Improgo, Eugen Tausch, et al.
Genome Biology|June 3, 2026
Publisher Correction: Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Blood|March 8, 2021
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemiaIshwarya Murali, Siddha Kasar, Aishath Naeem, et al.
Genome Biology|April 16, 2026
Single-cell epigenetic and transcriptomic states across the continuum of monoclonal B cell lymphocytosis to chronic lymphocytic leukemiaAnja C Rathgeber, Stacey M Fernandes, Adi Nagler, et al.
Blood|July 1, 2020
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLLMarco V Haselager, Karoline Kielbassa, Johanna Ter Burg, et al.
British Journal of Haematology|December 12, 2018
MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLLMa Reina Improgo, Bethany Tesar, Josephine L Klitgaard, et al.
Leukemia|July 28, 2025
Rare germline variant in NFATC4 associated with familial CLLGilad Itchaki, Harrison Bai, Grace Tiao, et al.
Haematologica|July 1, 2021
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisibVeronika Sandova, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Pageof 6